DK0811386T3 - Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks - Google Patents
Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleksInfo
- Publication number
- DK0811386T3 DK0811386T3 DK97302821T DK97302821T DK0811386T3 DK 0811386 T3 DK0811386 T3 DK 0811386T3 DK 97302821 T DK97302821 T DK 97302821T DK 97302821 T DK97302821 T DK 97302821T DK 0811386 T3 DK0811386 T3 DK 0811386T3
- Authority
- DK
- Denmark
- Prior art keywords
- salt
- solubility
- prepare
- selecting
- inclusion complex
- Prior art date
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Medical Informatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Seasonings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1686696P | 1996-05-07 | 1996-05-07 | |
EP97302821A EP0811386B1 (en) | 1996-05-07 | 1997-04-24 | Method of selecting a salt for making an inclusion complex |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0811386T3 true DK0811386T3 (da) | 2005-01-03 |
Family
ID=21779426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97302821T DK0811386T3 (da) | 1996-05-07 | 1997-04-24 | Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks |
Country Status (9)
Country | Link |
---|---|
US (1) | US20010007862A1 (da) |
EP (1) | EP0811386B1 (da) |
JP (2) | JP3007312B2 (da) |
AT (1) | ATE277641T1 (da) |
CA (1) | CA2204451C (da) |
DE (1) | DE69730902T2 (da) |
DK (1) | DK0811386T3 (da) |
ES (1) | ES2224205T3 (da) |
PT (1) | PT811386E (da) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA57734C2 (uk) | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
IL127497A (en) * | 1997-12-18 | 2002-07-25 | Pfizer Prod Inc | Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders |
BR0114757A (pt) * | 2000-10-19 | 2003-10-07 | Tibotec Bvba | Método e dispositivo para a manipulação de microveìculos com a finalidade de identificação |
US6884885B2 (en) | 2000-12-21 | 2005-04-26 | Cerestar Holding B.V. | Production of cyclodextrin complexes |
DE10215942A1 (de) * | 2002-04-11 | 2003-10-23 | Bayer Ag | Wässrige Formulierungen von (2-Hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorbutan-1-sulfonat |
EP1562546A1 (en) * | 2002-10-25 | 2005-08-17 | Pfizer Products Inc. | Depot formulations of arylheterocyclic active agents in the form of a suspension |
US20050266398A1 (en) * | 2004-06-01 | 2005-12-01 | Peter Lea | Method and device for rapid detection and quantitation of macro and micro matrices |
US20080300173A1 (en) * | 2004-07-13 | 2008-12-04 | Defrees Shawn | Branched Peg Remodeling and Glycosylation of Glucagon-Like Peptides-1 [Glp-1] |
CA2475191A1 (en) * | 2004-07-20 | 2006-01-20 | Biophys, Inc. | System and method for rapid reading of macro and micro matrices |
CA2475240A1 (en) * | 2004-07-20 | 2006-01-20 | Biophys, Inc. | Method and device to measure dynamic internal calibration true dose response curves |
CA2475456A1 (en) | 2004-07-20 | 2006-01-20 | Biophys, Inc. | Method and device to optimize analyte and antibody substrate binding by least energy adsorption |
WO2006086779A1 (en) * | 2005-02-11 | 2006-08-17 | Teva Pharmaceutical Industries Ltd. | Amorphous ziprasidone mesylate |
US20060258679A1 (en) * | 2005-02-11 | 2006-11-16 | Alex Mainfeld | Process of preparing ziprasidone mesylate |
US20060270685A1 (en) * | 2005-03-14 | 2006-11-30 | Judith Aronhime | Anhydrous ziprasidone mesylate and a process for its preparation |
US20060270684A1 (en) * | 2005-03-14 | 2006-11-30 | Judith Aronhime | Crystalline forms of ziprasidone mesylate |
CA2569971A1 (en) * | 2006-12-04 | 2008-06-04 | Umedik Inc. | Method for double-dip substrate spin optimization of coated micro array supports |
WO2011080749A1 (en) * | 2009-12-29 | 2011-07-07 | Hetero Research Foundation | Process for purification of ziprasidone |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1269578B (it) * | 1994-04-22 | 1997-04-08 | Chiesi Farma Spa | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo acido, una ciclodestrina e una base. |
UA57734C2 (uk) * | 1996-05-07 | 2003-07-15 | Пфайзер Інк. | Комплекси включення арилгетероциклічних солей |
-
1997
- 1997-04-24 DE DE69730902T patent/DE69730902T2/de not_active Expired - Fee Related
- 1997-04-24 ES ES97302821T patent/ES2224205T3/es not_active Expired - Lifetime
- 1997-04-24 DK DK97302821T patent/DK0811386T3/da active
- 1997-04-24 AT AT97302821T patent/ATE277641T1/de not_active IP Right Cessation
- 1997-04-24 EP EP97302821A patent/EP0811386B1/en not_active Expired - Lifetime
- 1997-04-24 PT PT97302821T patent/PT811386E/pt unknown
- 1997-05-02 US US08/850,353 patent/US20010007862A1/en not_active Abandoned
- 1997-05-05 CA CA002204451A patent/CA2204451C/en not_active Expired - Fee Related
- 1997-05-06 JP JP9115720A patent/JP3007312B2/ja not_active Expired - Fee Related
-
1999
- 1999-10-13 JP JP11291178A patent/JP2000086539A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2000086539A (ja) | 2000-03-28 |
CA2204451C (en) | 2004-06-29 |
DE69730902D1 (de) | 2004-11-04 |
US20010007862A1 (en) | 2001-07-12 |
PT811386E (pt) | 2004-12-31 |
JPH1059871A (ja) | 1998-03-03 |
ATE277641T1 (de) | 2004-10-15 |
MX9703304A (es) | 1998-05-31 |
JP3007312B2 (ja) | 2000-02-07 |
EP0811386B1 (en) | 2004-09-29 |
EP0811386A2 (en) | 1997-12-10 |
CA2204451A1 (en) | 1997-11-07 |
EP0811386A3 (en) | 1999-02-10 |
DE69730902T2 (de) | 2006-02-23 |
ES2224205T3 (es) | 2005-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0811386T3 (da) | Fremgangsmåde til udvælgelse af et salt til fremstilling af et inklusionskompleks | |
FI933702A (fi) | Menetelmä suhteellisen kosteuden mittaamiseksi, etenkin radiosondeissa | |
DE59505674D1 (de) | Verfahren und vorrichtung zum vermessen und markieren | |
DK0679216T3 (da) | Fremgangsmåde til bestemmelse af borehulsretning | |
DE69103930T2 (de) | Mess-Fühlerprobe. | |
DE59203135D1 (de) | Windkanal mit freistrahlmessstrecke zur simulation von windrichtungsschwankungen. | |
DK0511047T3 (da) | Fremgangsmåde til måling af dimensionerne på genstande, der er i bevægelse | |
FI100826B (fi) | Menetelmä kiiltoprofiilin mittaamiseksi | |
DE69101432D1 (de) | Verfahren zur meeresseismischendatenerfassung. | |
ATE494562T1 (de) | Verfahren zur erkennung und verfolgung von objekten | |
DE59207944D1 (de) | Korpuskularstrahltestverfahren mit Gegenspannungsnachführung | |
DE69411189T2 (de) | Rücktitrations-messverfahren unter verwendung von zweiverschiedenen markern | |
DE69818199D1 (de) | System und Methode zur Erzeugung paralleler Strahlen und Ebenen | |
DE3668621D1 (de) | Verfahren zur herstellung von pteridinderivaten. | |
DE69023496D1 (de) | Optische Sonde. | |
DE69101150T2 (de) | Verfahren zum Lokalisieren eines Fehlers. | |
DK0740789T3 (da) | Fremgangsmåde til at teste for mastitis i pattedyr samt system til udøvelse af fremgangsmåden | |
NO932466L (no) | Testsystem for feltmaaling | |
PA8477601A1 (es) | Inhibidores de las fkbp | |
DE69204383T2 (de) | Verfahren zur Harmonisierung von Kamerazielachsen. | |
DE59202288D1 (de) | Verfahren zur Gewinnung fester Farbstoffe. | |
AU8940291A (en) | A method for aligning a feeding beam in a rock drilling equipment and a rock drilling equipment and a measuring device | |
DE68904045D1 (de) | Referenzstrahlprojektionsapparat zur verwendung in vermessungseinrichtungen. | |
SE9600623D0 (sv) | Automation methodology for 3 D image metrology systems | |
DE69210619T2 (de) | Temperaturmessung am ausgang eines verdampfers |